Fibroblast Activation Protein–Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial

Lukas Kessler; Felix Schwaning; Martin Metzenmacher; Kim Pabst; Jens Siveke; Marija Trajkovic-Arsic; Benedikt Schaarschmidt; Marcel Wiesweg; Clemens Aigner; Till Plönes; Kaid Darwiche; Servet Bölükbas; Martin Stuschke; Lale Umutlu; Michael Nader; Dirk Theegarten; Rainer Hamacher; Wilfried E.E. Eberhardt; Martin Schuler; Ken Herrmann; Wolfgang P. Fendler; Hubertus Hautzel

doi:10.2967/jnumed.124.267473

Research ArticleClinical Investigation

Fibroblast Activation Protein–Directed Imaging Outperforms ¹⁸F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial

Lukas Kessler, Felix Schwaning, Martin Metzenmacher, Kim Pabst, Jens Siveke, Marija Trajkovic-Arsic, Benedikt Schaarschmidt, Marcel Wiesweg, Clemens Aigner, Till Plönes, Kaid Darwiche, Servet Bölükbas, Martin Stuschke, Lale Umutlu, Michael Nader, Dirk Theegarten, Rainer Hamacher, Wilfried E.E. Eberhardt, Martin Schuler, Ken Herrmann, Wolfgang P. Fendler and Hubertus Hautzel

Journal of Nuclear Medicine July 2024, jnumed.124.267473; DOI: https://doi.org/10.2967/jnumed.124.267473

Lukas Kessler

1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;

2Institute of Diagnostic and Interventional Radiology and Neuroradiology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;

3German Cancer Consortium, Partner Site Essen, Essen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Felix Schwaning

1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;

3German Cancer Consortium, Partner Site Essen, Essen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Martin Metzenmacher

3German Cancer Consortium, Partner Site Essen, Essen, Germany;

4Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kim Pabst

1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;

3German Cancer Consortium, Partner Site Essen, Essen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jens Siveke

4Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;

5Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, Essen, Germany;

6Division of Solid Tumor Translational Oncology, German Cancer Consortium, Partner Site Essen, Essen, Germany;

7German Cancer Research Center, Heidelberg, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marija Trajkovic-Arsic

5Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, Essen, Germany;

6Division of Solid Tumor Translational Oncology, German Cancer Consortium, Partner Site Essen, Essen, Germany;

7German Cancer Research Center, Heidelberg, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Benedikt Schaarschmidt

2Institute of Diagnostic and Interventional Radiology and Neuroradiology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marcel Wiesweg

3German Cancer Consortium, Partner Site Essen, Essen, Germany;

4Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Clemens Aigner

8Department of Thoracic Surgery and Thoracic Endoscopy, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;

9Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Till Plönes

7German Cancer Research Center, Heidelberg, Germany;

8Department of Thoracic Surgery and Thoracic Endoscopy, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;

10Division of Thoracic Surgery, Department of Visceral, Thoracic, and Vascular Surgery, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany;

11National Center for Tumor Diseases, Dresden, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; and Helmholtz-Zentrum Dresden–Rossendorf, Dresden, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kaid Darwiche

12Department of Pulmonary Medicine, Section of Interventional Pulmonology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Servet Bölükbas

8Department of Thoracic Surgery and Thoracic Endoscopy, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Martin Stuschke

13Department of Radiotherapy, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lale Umutlu

2Institute of Diagnostic and Interventional Radiology and Neuroradiology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael Nader

1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;

3German Cancer Consortium, Partner Site Essen, Essen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Dirk Theegarten

14Institute of Pathology, University Hospital Essen, University of Duisburg–Essen, Essen, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rainer Hamacher

3German Cancer Consortium, Partner Site Essen, Essen, Germany;

4Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wilfried E.E. Eberhardt

3German Cancer Consortium, Partner Site Essen, Essen, Germany;

15Division of Thoracic Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Martin Schuler

3German Cancer Consortium, Partner Site Essen, Essen, Germany;

4Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ken Herrmann

1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;

3German Cancer Consortium, Partner Site Essen, Essen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wolfgang P. Fendler

1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;

3German Cancer Consortium, Partner Site Essen, Essen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hubertus Hautzel

1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;

3German Cancer Consortium, Partner Site Essen, Essen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 65, Issue 10

October 1, 2024

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Fibroblast Activation Protein–Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Fibroblast Activation Protein–Directed Imaging Outperforms ¹⁸F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial

Journal of Nuclear Medicine Jul 2024, jnumed.124.267473; DOI: 10.2967/jnumed.124.267473

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Fibroblast Activation Protein–Directed Imaging Outperforms ¹⁸F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial

Journal of Nuclear Medicine Jul 2024, jnumed.124.267473; DOI: 10.2967/jnumed.124.267473

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

mesothelioma
cancer imaging
FAPI
fibroblast activation protein
thoracic cancer

Main menu

User menu

Search

Fibroblast Activation Protein–Directed Imaging Outperforms ¹⁸F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords